Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima,
No information about this author
Lucas Fornari Laurindo,
No information about this author
Vitor Cavallari Strozze Catharin
No information about this author
et al.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(2), P. 124 - 124
Published: Feb. 13, 2025
Neurodegenerative
diseases
comprise
a
group
of
chronic,
usually
age-related,
disorders
characterized
by
progressive
neuronal
loss,
deformation
structure,
or
loss
function,
leading
to
substantially
reduced
quality
life.
They
remain
significant
focus
scientific
and
clinical
interest
due
their
increasing
medical
social
importance.
Most
neurodegenerative
present
intracellular
protein
aggregation
extracellular
deposition
(plaques),
such
as
α-synuclein
in
Parkinson's
disease
amyloid
beta
(Aβ)/tau
aggregates
Alzheimer's.
Conventional
treatments
for
conditions
incur
high
costs
are
related
the
development
several
adverse
effects.
In
addition,
many
patients
irresponsive
them.
For
these
reasons,
there
is
growing
tendency
find
new
therapeutic
approaches
help
patients.
This
review
intends
investigate
some
phytocompounds'
effects
on
diseases.
These
generally
increased
oxidative
stress
inflammation,
so
phytocompounds
can
prevent
treat
To
achieve
our
aim
provide
critical
assessment
current
literature
about
phytochemicals
targeting
neurodegeneration,
we
reviewed
reputable
databases,
including
PubMed,
EMBASE,
COCHRANE,
seeking
trials
that
utilized
against
conditions.
A
few
investigated
humans,
after
screening,
13
were
ultimately
included
following
PRISMA
guidelines.
compounds
include
polyphenols
(flavonoids
luteolin
quercetin,
phenolic
acids
rosmarinic
acid,
ferulic
caffeic
other
like
resveratrol),
alkaloids
(such
berberine,
huperzine
A,
caffeine),
terpenoids
ginkgolides
limonene).
The
gathered
evidence
underscores
caffeine,
ginkgolides,
primarily
anti-inflammatory,
antioxidant,
neuroprotective,
counteracting
neuroinflammation,
oxidation,
synaptic
dysfunctions,
which
crucial
aspects
intervention
various
conditions,
Alzheimer's
dementias,
depression,
neuropsychiatric
disorders.
summary,
they
show
use
improvements
cognition,
memory,
disinhibition,
irritability/lability,
aberrant
behavior,
hallucinations,
mood
Language: Английский
Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4368 - 4368
Published: Dec. 18, 2024
The
brain
contains
many
interconnected
and
complex
cellular
molecular
mechanisms.
Injury
to
the
causes
permanent
dysfunctions
in
these
So,
it
continues
be
an
area
where
surgical
intervention
cannot
performed
except
for
removal
of
tumors
repair
some
aneurysms.
Some
agents
that
can
cross
blood–brain
barrier
reach
neurons
show
neuroprotective
effects
due
their
anti-apoptotic,
anti-inflammatory
antioxidant
properties.
In
particular,
act
by
reducing
or
modulating
accumulation
protein
aggregates
neurodegenerative
diseases
(Alzheimer’s
disease,
Parkinson’s
Huntington’s
Amyotrophic
lateral
sclerosis,
prion
disease)
caused
accumulation.
Substrate
increased
oxidative
stress
stimulates
brain’s
immune
cells,
microglia,
astrocytes,
secrete
proinflammatory
cytokines.
Long-term
chronic
neuroinflammatory
response
triggers
apoptosis.
Brain
damage
is
observed
with
neuronal
apoptosis
functions
are
impaired.
This
situation
negatively
affects
processes
such
as
motor
movements,
memory,
perception,
learning.
Neuroprotective
prevent
molecules
play
a
role
addition,
they
improve
impaired
supporting
neuroplasticity
neurogenesis.
Due
important
roles
central
nervous
system
diseases,
elucidate
review
provides
overview
mechanisms
flavonoids,
which
constitute
large
part
effects,
well
vitamins,
neurotransmitters,
hormones,
amino
acids,
derivatives.
It
thought
understanding
will
enable
development
new
therapeutic
different
treatment
strategies.
Language: Английский
Development of a Population Pharmacokinetic Model Characterizing the Tissue Distribution of Resveratrol After Administration by Different Routes and Doses in Rats
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(1), P. 181 - 181
Published: Jan. 3, 2025
Background:
Studies
have
demonstrated
that
resveratrol
exerts
several
pharmacological
effects.
However,
the
pharmacokinetic
parameters
are
not
completely
established.
Objectives:
This
study
describes
plasma
pharmacokinetics
and
tissue
distribution
of
after
administration
by
different
routes
doses
in
rats.
Methods:
A
reliable,
simple,
sensitive
HPLC
method
using
UV
detection
for
quantification
rat
tissues
was
developed
validated.
In
addition,
a
analysis
non-compartmental
population
modeling
performed.
Results:
The
5
mg/kg
via
i.v.
bolus
calculated
were
constant
elimination
(ke)
0.09
h−1
±
0.04,
half-life
(t1/2)
9.5
h
3.7,
an
apparent
volume
(Vd)
5.8
L/kg
4.7,
clearance
(Cl)
0.39
L/h/Kg
0.26,
area
under
curve
(AUC)
6076
ng/h/mL
2959.
results
obtained
100
p.o.
0.12
0.07
h−1,
7.9
4.2
h,
13.3
3.3
L/kg,
1.76
0.49
6519
1592
ng/h/mL.
For
analysis,
10
intravenously
administered
to
rats
molecule
quantified
liver,
lung,
kidney,
heart,
stomach,
spleen,
adipose
tissue,
brain
animals.
Conclusions:
showed
has
two-compartment
model
both
higher
when
it
is
given
orally.
high
concentration
iv
administration,
which
indicates
this
capable
crossing
blood–brain
barrier
animals,
crucial
capacity
its
neuroprotective
activity.
Language: Английский
Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(1), P. 132 - 132
Published: Jan. 20, 2025
Resveratrol,
a
bioactive
phytoalexin,
has
been
extensively
studied
as
pharmaceutical
and
nutraceutical
candidate
for
the
treatment
of
various
diseases.
Although
its
therapeutic
effects
have
largely
attributed
to
anti-oxidant
properties,
underlying
mechanisms
dose
dependency
are
not
well
understood.
Recent
studies
shown
that
cell-free
chromatin
particles
(cfChPs),
which
released
daily
from
billions
dying
cells,
can
enter
circulation
be
internalized
by
healthy
wherein
they
trigger
damaging
effects,
including
double-strand
DNA
breaks.
Notably,
deactivating
cfChPs
using
mixture
resveratrol
copper
neutralize
their
harmful
effects.
The
addition
imparts
novel
property
viz.
generation
reactive
oxygen
species
(ROS),
capable
without
genomic
DNA.
This
perspective
article
discusses
how
deactivation
via
ROS
generated
combining
with
multiple
Exploiting
deactivate
ameliorate
disease
conditions
may
viable
approach.
Language: Английский
Neuroprotective effects of hirudin against cerebral ischemia-reperfusion injury via inhibition of CCL2-mediated ferroptosis and inflammatory pathways
J. Y. Liao,
No information about this author
Huahui Chen,
No information about this author
Yiwei Liao
No information about this author
et al.
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
unknown, P. 111293 - 111293
Published: March 1, 2025
Cerebral
ischemia-reperfusion
injury
(CIRI)
is
a
leading
cause
of
neurological
impairment
in
stroke,
primarily
correlated
to
oxidative
stress,
inflammation,
and
ferroptosis.
This
study
investigates
the
neuroprotective
effects
hirudin
on
CIRI,
focusing
its
role
modulating
neuronal
survival,
ferroptosis
markers
through
inhibition
CCL2.
A
middle
cerebral
artery
occlusion
(MCAO)
model
mice
an
oxygen-glucose
deprivation/reoxygenation
(OGD/R)
HT22
cells
were
used
simulate
ischemic
conditions.
Hirudin
significantly
improved
function
reduced
edema
infarct
size
MCAO
model.
In
vitro,
enhanced
viability
apoptosis
OGD/R-stimulated
cells.
Integrative
network
pharmacology
transcriptomic
analysis
identified
CCL2
as
potential
target
hirudin.
treatment
suppressed
expression,
which
turn
TLR4/NF-κB
signaling
activation,
thereby
mitigating
inflammatory
responses
neurons.
Overexpression
partially
reversed
these
protective
effects,
underscoring
injury.
These
findings
suggest
that
alleviates
CIRI
by
preventing
ferroptosis,
offering
insights
into
therapeutic
agent
for
Language: Английский
Multitarget Natural Compounds for Ischemic Stroke Treatment: Integration of Deep Learning Prediction and Experimental Validation
Junyu Zhou,
No information about this author
Chen Li,
No information about this author
Yue Yu
No information about this author
et al.
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 14, 2025
Ischemic
stroke's
complex
pathophysiology
demands
therapeutic
approaches
targeting
multiple
pathways
simultaneously,
yet
current
treatments
remain
limited.
We
developed
an
innovative
drug
discovery
pipeline
combining
a
deep
learning
approach
with
experimental
validation
to
identify
natural
compounds
comprehensive
neuroprotective
properties.
Our
computational
framework
integrated
SELFormer,
transformer-based
model,
and
algorithms
predict
NC
bioactivity
against
seven
crucial
stroke-related
targets
(ACE,
GLA,
MMP9,
NPFFR2,
PDE4D,
eNOS).
The
encompassed
IC50
predictions,
clustering
analysis,
quantitative
structure-activity
relationship
(QSAR)
modeling,
uniform
manifold
approximation
projection
(UMAP)-based
profiling
followed
by
molecular
docking
studies
validation.
Analysis
revealed
six
distinct
clusters
unique
signatures.
UMAP
identified
11
medium-activity
(6
<
pIC50
≤
7)
57
high-activity
(pIC50
>
compounds,
confirming
strong
correlations
between
binding
energies
predicted
values.
In
vitro
using
NGF-differentiated
PC12
cells
under
oxygen-glucose
deprivation
demonstrated
significant
effects
of
four
compounds:
feruloyl
glucose,
l-hydroxy-l-tryptophan,
mulberrin,
ellagic
acid.
These
enhanced
cell
viability,
reduced
acetylcholinesterase
activity
lipid
peroxidation,
suppressed
TNF-α
expression,
upregulated
BDNF
mRNA
levels.
Notably,
mulberrin
acid
showed
superior
efficacy
in
modulating
oxidative
stress,
inflammation,
neurotrophic
signaling.
This
study
establishes
robust
learning-driven
for
identifying
multitarget
therapeutics
ischemic
stroke.
validated
particularly
acid,
are
promising
stroke
treatment
development.
findings
demonstrate
the
effectiveness
integrating
prediction
accelerating
neurological
disorders.
Language: Английский
Post-Stroke Recovery: A Review of Hydrogel-Based Phytochemical Delivery Systems
Gels,
Journal Year:
2025,
Volume and Issue:
11(4), P. 260 - 260
Published: April 1, 2025
Stroke
remains
a
leading
cause
of
disability
worldwide,
underscoring
the
urgent
need
for
novel
and
innovative
therapeutic
strategies
to
enhance
neuroprotection,
support
regeneration,
improve
functional
recovery.
Previous
research
has
shown
that
phytochemicals
such
as
curcumin,
tannic
acid,
gallic
ginsenosides,
resveratrol,
isorhamnetin
display
extensive
neuroprotective
properties,
including
antioxidant,
anti-inflammatory,
anti-apoptotic
effects.
These
natural
compounds
could
also
promote
neurogenesis,
angiogenesis,
preservation
blood–brain
barrier.
Despite
their
promising
bioactivities,
clinical
application
is
often
limited
by
poor
solubility,
bioavailability,
suboptimal
pharmacokinetics.
Hydrogels
offer
solution
encapsulating
controlling
gradual
release
these
directly
at
site
injury.
Recent
advancements
in
hydrogel
formulations,
constructed
from
biopolymers
functionalized
using
nanotechnological
approaches,
significantly
stability,
targeted
delivery
phytochemicals.
Controlled
profiles
pH-sensitive
environment-responsive
hydrogels
ensure
compounds’
effects
are
optimally
timed
with
individual
critical
stages
post-stroke
repair.
Moreover,
scaffolds
tailored
material
properties
biocompatibility
can
create
favorable
microenvironment,
reducing
secondary
inflammation,
enhancing
tissue
potentially
improving
cognitive
outcomes
following
stroke.
This
review
explores
potential
integrating
within
hydrogel-based
systems
specifically
designed
The
design
synthesis
biocompatible,
biodegradable
especially
applications
discussed.
Lastly,
we
emphasize
additional
robust
translatable
preclinical
studies.
Language: Английский
Targeting the Ischemic Core: A Therapeutic Microdialytic Approach to Prevent Neuronal Death and Restore Functional Behaviors
May‐Jywan Tsai,
No information about this author
Dann‐Ying Liou,
No information about this author
Li-Yu Fay
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3821 - 3821
Published: April 17, 2025
Ischemic
stroke
leads
to
cerebral
ionic
imbalance,
increases
acidosis,
oxidative
stress
and
release
of
glutamate
inflammatory
mediators.
Removing
solute
or
stimulants
from
the
ischemic
core
may
block
cell-damaging
events
confer
neuroprotection.
In
this
study,
we
developed
a
minimally
invasive
therapeutic
microdialysis
(tMD)
method,
choosing
include
serum
albumin
in
buffer
because
it
is
multifunctional
protein
with
osmotic
properties.
Aiming
at
core,
continuous
perfusion
supplemented
agents
removes
mediators
inflammation/cell
damage/death
lesion.
This
tMD
treatment
significantly
removed
zinc
ions
thereby
reducing
infarct
volumes
affording
high-grade
neurobehavioral
protection
against
stroke.
The
effectively
protected
neurons
reduced
microglial
activation.
Furthermore,
approach
extended
window
protect
beyond
6
h
after
onset.
These
findings
support
potential
clinical
feasibility
applying
patients
stroke,
potentially
without
adverse
effects.
Language: Английский
Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC
Yurou Guo,
No information about this author
Jing Li,
No information about this author
Xiaodan Liu
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 28, 2025
Ischemic
stroke
(IS)
remains
a
leading
cause
of
mortality
and
disability
worldwide,
driven
by
genetic
predispositions
environmental
interactions,
with
epigenetics
playing
pivotal
role
in
mediating
these
processes.
Specific
modifying
enzymes
that
regulate
epigenetic
changes
have
emerged
as
promising
targets
for
IS
treatment.
DNA
methyltransferases
(DNMTs),
ten-eleven
translocation
(TET)
dioxygenases,
histone
acetyltransferases
(HATs),
deacetylases
(HDACs)
are
central
to
regulation.
These
maintain
dynamic
balance
between
methylation/demethylation
acetylation/deacetylation,
which
critically
influences
gene
expression
neuronal
survival
IS.
This
review
is
based
on
both
vivo
vitro
experimental
studies,
exploring
the
roles
DNMT/TET
HAT/HDAC
IS,
evaluating
their
potential
therapeutic
targets,
discussing
use
natural
compounds
modulators
develop
novel
treatment
strategies.
Language: Английский
Role of Akkermansia muciniphila in insulin resistance
Journal of Gastroenterology and Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 13, 2024
Abstract
Insulin
resistance
(IR)
is
a
pathogenic
factor
in
numerous
metabolic
diseases.
The
gut
microbiota
plays
crucial
role
maintaining
the
function
of
intestinal
barrier
and
overall
human
health,
thereby
influencing
IR.
Dysbiosis
can
contribute
to
development
Therefore,
it
essential
maintain
balanced
diverse
for
optimal
health.
Akkermansia
muciniphila
,
widely
present
microorganism
intestine,
has
been
shown
regulate
gastrointestinal
mucosal
integrity,
reduce
endotoxin
penetration,
decrease
systemic
inflammation
levels,
improve
insulin
sensitivity.
Reduced
abundance
A.
associated
with
an
increased
risk
IR
other
diseases,
highlighting
its
correlation
Understanding
regulatory
mechanism
comprehending
pathogenesis
developing
novel
strategies
preventing
treating
related
disorders.
Individual
variations
may
exist
both
composition
impact
on
among
different
individuals.
Further
investigation
into
individual
differences
between
will
facilitate
advancements
personalized
medicine
by
promoting
tailored
interventions
based
composition,
which
potential
future
direction
that
would
optimize
sensitivity
while
disease
occurrence.
In
this
review,
we
describe
physiological
characteristics
emphasize
roles
underlying
mechanisms
contributing
pathology,
summarize
how
alterations
affect
development,
providing
valuable
insights
further
research
as
well
new
drug
targeting
diabetes.
Language: Английский